Vaxxinity, Inc. (VAXX)
NASDAQ: VAXX · IEX Real-Time Price · USD
0.476
+0.011 (2.43%)
At close: Apr 19, 2024, 4:00 PM
0.210
-0.266 (-55.89%)
After-hours: Apr 19, 2024, 7:59 PM EDT

Vaxxinity Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022202120202019
Market Capitalization
60108176703--
Market Cap Growth
--38.95%-74.91%---
Enterprise Value
45921035693114
PE Ratio
-1.89-1.89-2.35-5.13--
PS Ratio
---10658.50--
PB Ratio
4.508.032.845.47--
P/FCF Ratio
-1.86-1.86-3.05-8.55--
P/OCF Ratio
-1.88-1.88-3.16-8.69--
EV/Sales Ratio
---8622.7756.43-
EV/EBITDA Ratio
-1.71-1.71-1.41-4.21-0.83-1.02
EV/EBIT Ratio
-1.64-1.64-1.38-4.17-0.81-1.01
EV/FCF Ratio
-1.59-1.59-1.78-6.91-0.89-1.13
Debt / Equity Ratio
1.131.130.230.08-0.72-0.29
Debt / EBITDA Ratio
-0.28-0.28-0.20-0.08-1.65-1.05
Debt / FCF Ratio
-0.26-0.26-0.25-0.13-1.77-1.17
Quick Ratio
1.731.732.845.290.800.04
Current Ratio
1.891.893.035.610.910.07
Asset Turnover
0000.000.02-
Interest Coverage
-80.80-80.80-145.35-162.30-32.80-31.56
Return on Equity (ROE)
-192.60%-192.60%-85.40%-665.20%58.80%-
Return on Assets (ROA)
-88.00%-88.00%-58.60%-126.50%-154.50%-
Return on Capital (ROIC)
-203.96%-203.96%-99.03%-89.78%130.44%39.94%
Earnings Yield
-94.35%-52.85%-42.62%-19.50%--
FCF Yield
-96.18%-53.87%-32.75%-11.70%--
Buyback Yield / Dilution
-0.45%-0.45%-64.44%-16.68%-23.31%-
Total Shareholder Return
-0.45%-0.45%-64.44%-16.68%-23.31%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).